Hjem › Eggstokkreft › Virginia › Arlington
Kliniske studier for Eggstokkreft i Arlington, VA
46 studier for Eggstokkreft søker deltakere på steder i og rundt Arlington (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
- Inova Fair Oaks Hospital, Fairfax · 11 mi unna
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruttererFase 2
- Inova Fairfax Hospital, Falls Church · 4 mi unna
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RekruttererFase 1/2
- Research Site, Fairfax · 11 mi unna
A Study of PHST001 in Advanced Solid Tumors
RekruttererFase 1
- NEXT Oncology - Virginia, Fairfax · 11 mi unna
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
- NEXT Virginia, Fairfax · 11 mi unna
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi unna
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruttererFase 1
- NEXT Virginia, Fairfax · 11 mi unna
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
RekruttererFase 2
- Next Virginia /ID# 279684, Fairfax · 11 mi unna
A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
RekruttererFase 1
- Site 04, Fairfax · 11 mi unna
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
RekruttererFase 1
- Next Virginia /ID# 278607, Fairfax · 11 mi unna
First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer
RekruttererFase 1/2
- NEXT Virginia, Fairfax · 11 mi unna
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RekruttererFase 2
- Inova Schar Cancer Institute - Fairfax - Innovation Park Drive /ID# 276456, Fairfax · 11 mi unna
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
RekruttererFase 2
- Site 0322 - Inova Schar Cancer Institute, Fairfax · 11 mi unna
Study of AVZO-021 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Avenzo Therapeutics Recruiting Site, Fairfax · 11 mi unna
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi unna
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruttererFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi unna
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
RekruttererFase 3
- Virginia Cancer Specialists (VCS) ( Site 8012), Fairfax · 11 mi unna
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
RekruttererFase 1/2
- NEXT Oncology, Fairfax · 11 mi unna
Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RekruttererFase 3
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
RekruttererFase 2
- Virginia Cancer Specialists, Fairfax · 11 mi unna
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
RekruttererFase 1/2
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
- Next Oncology Virginia, Fairfax · 11 mi unna
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruttererFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi unna
Phase 1 Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Antitumor Activity of ARR-002 in Advanced or Metastatic Ovarian or Endometrial Cancer.
RekruttererFase 1
- NEXT Oncology, Fairfax · 11 mi unna
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
RekruttererFase 3
- Virginia Cancer Specialists (VCS) ( Site 8011), Fairfax · 11 mi unna
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
RekruttererFase 1
- Inova Schar Cancer Institute, Falls Church · 4 mi unna
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekruttererFase 1
- Normunity Investigational Site, Fairfax · 11 mi unna
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Rekrutterer
- Inova Fairfax Hospital, Falls Church · 4 mi unna
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
- Inova Fair Oaks Hospital, Fairfax · 11 mi unna
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- Clinical Trial Site, Fairfax · 11 mi unna
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekruttererFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi unna
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
RekruttererFase 1
- NEXT Oncology - Virginia Cancer Specialists, Fairfax · 11 mi unna
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
RekruttererFase 1/2
- USOR Virginia Cancer Specialists, Fairfax · 11 mi unna
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi unna
Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
RekruttererFase 1
- NEXT Virginia, Fairfax · 11 mi unna
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekruttererFase 2
- 522, Fairfax · 11 mi unna
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- USO-Virginia Cancer Specialists, PC, Fairfax · 11 mi unna
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
RekruttererFase 1
- NEXT Virginia, Fairfax · 11 mi unna
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruttererFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi unna
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid Tumors
RekruttererFase 1/2
- NEXT Oncology Virginia, Fairfax · 11 mi unna
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
RekruttererFase 1/2
- NEXT, Fairfax · 11 mi unna
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer
RekruttererFase 3
- Inova Schar Cancer Institute, Fairfax · 11 mi unna
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
RekruttererFase 1
- NEXT Oncology Virginia, Fairfax · 11 mi unna
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RekruttererFase 1/2
- Virginia Cancer Specialists, Fairfax · 11 mi unna
First in Human Study of TORL-1-23 in Participants With Advanced Cancer
RekruttererFase 1
- Virginia Cancer Specialists, Fairfax · 11 mi unna
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors
RekruttererFase 1
- NEXT Oncology, Fairfax · 11 mi unna
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
RekruttererFase 1
- Dren Investigational Site, Fairfax · 11 mi unna
A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors
RekruttererFase 1
- Next Oncology, Virginia Cancer Specialists, Fairfax · 11 mi unna
Eggstokkreft-studier i andre byer
- Houston, TX89 studier
- New York City, NY69 studier
- Boston, MA61 studier
- Los Angeles, CA50 studier
- Nashville, TN49 studier
- Philadelphia, PA44 studier
- Columbus, OH39 studier
- St. Louis, MO38 studier
- Chicago, IL36 studier
- San Antonio, TX31 studier
- Cleveland, OH30 studier
- Pittsburgh, PA30 studier
Andre studier i Arlington
- Ikke-småcellet lungekreft104 studier
- Metastatisk kreft53 studier
- Kolorektal kreft52 studier
- Kreft (alle typer)48 studier
- Brystkreft47 studier
- Lungekreft41 studier
- Endometriekreft39 studier
- Pankreaskreft33 studier
- Plateepitelcancer i hode og hals26 studier
- Småcellet lungekreft23 studier
- Mavekreft20 studier
- Tripelnegativ brystkreft20 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.